Breakthrough Pain clinical trials
The registry lists 34 studies for Breakthrough Pain across more than 10 countries. 4 are recruiting or about to start. 21 of them are mainly about Breakthrough Pain (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-18.
Get an email when these change. Save the Breakthrough Pain studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Cephalon (6) · Angelini Farmacéutica (3) · KK Women's and Children's Hospital (2) · Kyowa Kirin Co., Ltd. (2) · Holy Family Hospital, Nazareth, Israel (2) · University of Surrey (1) · UNICANCER (1) · Alexza Pharmaceuticals, Inc. (1)
What is being tested here
Drugs under test in Breakthrough Pain studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here Opioids 2 open · Local anesthetics 2 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 2
- Nov 2026Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous Women · Holy Family Hospital, Nazareth, Israel
- Nov 2026PIEB Compared With CEI on Breakthrough Pain in Nulliparous Women · Holy Family Hospital, Nazareth, Israel
Who these studies take
Of the 3 Breakthrough Pain studies recruiting now, 3 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 2 (67%) take children under 18. 3 (100%) are for women only and 0 (0%) for men only; 2 (67%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (67%) | 0 (0%) |
| 18 | 3 (100%) | 0 (0%) |
| 30 | 3 (100%) | 0 (0%) |
| 40 | 3 (100%) | 0 (0%) |
| 50 | 3 (100%) | 0 (0%) |
| 65 | 3 (100%) | 0 (0%) |
| 75 | 3 (100%) | 0 (0%) |
| 85 | 3 (100%) | 0 (0%) |
Across all 34 studies, recruiting or not: 15% stop at 75 or younger and 12% at 65; 18% take children; 18% are for women only and 0% for men only; 18% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 34 of 34. search them.
- Failing Epidural Analgesia During LaborRecruitingNCT074736091 country
- Programmed Intermittent Epidural Bolus Compared With Continuous Infusion in Multiparous WomenRecruitingNCT06580327Not applicable1 country
- PIEB Compared With CEI on Breakthrough Pain in Nulliparous WomenRecruitingNCT06494280Not applicable1 country
- Paediatric Breakthrough Pain AssessmentNot yet recruitingNCT06790719
- Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During LabourActive, not recruitingNCT04011150Phase 31 country
- Comparison of Regimens MPIB, CIPCEA, PCEAActive, not recruitingNCT02278601Phase 31 country
- Dexamethasone-Enhanced TAP Block in LapcholeActive, not recruitingNCT07182110Phase 11 country
- Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer PatientsCompletedNCT00263575Phase 31 country
- Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid RequirementWithdrawnNCT05053308Not applicable
- The Cancer Pain and Unmet Needs StudyTerminatedNCT016519101 country
- A Prospective Pilot Study of a Non-Narcotic Post-Operative Course After ColectomyStatus unknownNCT05200806Phase 41 country
- Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough PainCompletedNCT05037539Phase 1/21 country
- Patient Controlled Intrathecal Analgesia With Bupivacaine for Chronic Low Back PainCompletedNCT02886286Phase 41 country
- Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer PatientsWithdrawnNCT03809455Phase 2
- Quality of Life Study Breakthrough Cancer Pain Treated in Medical Oncology Services (CAVIDIOM)CompletedNCT034351201 country
- Analgesic Efficacy of Transmucosal Fentanyl for Breakthrough Pain Caused by Interventional GastrostomyCompletedNCT02869321Phase 41 country
- Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain OutpatientsTerminatedNCT02591017Phase 31 country
- Quality of Life Study Breakthrough Cancer Pain Treated in Radiation Oncology Services With Palliative IntentCompletedNCT028363791 country
- Quality of Life Study in Patients With Cancer Breakthrough Pain Treated in Palliative Care UnitsCompletedNCT028405001 country
- Sublingual Methadone for the Management of Cancer Breakthrough PainCompletedNCT00125294Phase 1
- Staccato Fentanyl Single and Multidose PKCompletedNCT00402350Phase 11 country
- A Comparative Study of KW-2246CompletedNCT01326689Phase 31 country
- Procedural Pain in Palliative Care: Prevalence, Intensity and TreatmentCompletedNCT024379291 country
- Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal MucositisCompletedNCT020505031 country
- An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.TerminatedNCT019017181 country
- Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)CompletedNCT00236041Phase 22 countries
- Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With CancerCompletedNCT01842893Phase 31 country
- Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough PainCompletedNCT00236145Phase 3
- Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough PainTerminatedNCT00387010Phase 31 country
- Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant PatientsTerminatedNCT00842829Phase 47 countries
- Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 YearsCompletedNCT009947601 country
- Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic PainCompletedNCT00813488Phase 31 country
- Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through PainCompletedNCT00463047Phase 31 country
- An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer PatientsCompletedNCT00576173Phase 4